MeVac - Meilahti Vaccine Research Center ( Site 1200)

Helsinki, Uusimaa 00290

1 studies enrolling now · 1 studies all time

What they study most

Coronavirus Disease (COVID-19)

Studies at this site

• A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) — Recruiting now